This topic contains a solution. Click here to go to the answer

Author Question: A client is prescribed a medication that will block muscarinic receptors. The nurse realizes that ... (Read 69 times)

sabina

  • Hero Member
  • *****
  • Posts: 563
A client is prescribed a medication that will block muscarinic receptors. The nurse realizes that this medication has implications for which body systems?
 
  Standard Text: Select all that apply.
  1. Eyes
  2. Respiratory
  3. Cardiac
  4. Endocrine
  5. Metabolic

Question 2

The nurse educator is reviewing the process of synaptic transmission across the neuroeffector junction with a student. In which order will the nurse explain the steps of synaptic transmission?
 
  Standard Text: Click on the down arrow for each response in the right column and select the correct choice from the list.
  Response 1. Synthesis of the neurotransmitter
  Response 2. Storage of the neurotransmitter
  Response 3. Release of the neurotransmitter
  Response 4. Binding to the receptor
  Response 5. Termination of neurotransmitter action



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

s.meritte

  • Sr. Member
  • ****
  • Posts: 306
Answer to Question 1

Correct Answer: 1,2,3
Rationale 1: Medications that block muscarinic receptors are used during ophthalmic procedures.
Rationale 2: Medications that block muscarinic receptors are used in the pharmacologic treatment of asthma.
Rationale 3: Medications that block muscarinic receptors are used in the pharmacologic treatment of bradycardia.
Rationale 4: Medications that block muscarinic receptors are not used in the treatment of endocrine disorders.
Rationale 5: Medications that block muscarinic receptors are not used in the treatment of metabolic disorders.
Global Rationale: Medications that block muscarinic receptors are used during ophthalmic procedures, to treat asthma, and to treat bradycardia. Medications that block muscarinic receptors are not used in the treatment of endocrine disorders or metabolic disorders.

Answer to Question 2

Correct Answer: 1,2,3,4,5
Rationale 1: This is the first step of synaptic transmission across the neuroeffector junction.
Rationale 2: This is the second step of synaptic transmission across the neuroeffector junction.
Rationale 3: This is the third step of synaptic transmission across the neuroeffector junction.
Rationale 4: This is the fourth step of synaptic transmission across the neuroeffector junction.
Rationale 5: This is the fifth step of synaptic transmission across the neuroeffector junction.
Global Rationale: The steps of synaptic transmission across the neuroeffector junction are 1) synthesis of the neurotransmitter; 2) storage of the neurotransmitter; 3) release of the neurotransmitter; 4) binding to the receptor; and 5) termination of neurotransmitter action.




sabina

  • Member
  • Posts: 563
Reply 2 on: Jul 23, 2018
:D TYSM


nothere

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

Colchicine is a highly poisonous alkaloid originally extracted from a type of saffron plant that is used mainly to treat gout.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

Drug-induced pharmacodynamic effects manifested in older adults include drug-induced renal toxicity, which can be a major factor when these adults are experiencing other kidney problems.

Did you know?

Increased intake of vitamin D has been shown to reduce fractures up to 25% in older people.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

For a complete list of videos, visit our video library